General Information
|
|
Product
|
Phospho-Src Peptide
|
Description
|
Antigenic Blocking Peptide Phosphorylated Proto-oncogene tyrosine-protein kinase Src Antibody N-epitope
|
Verified Applications
|
Immunocompetition, Immunodepletion
|
Peptide Description
|
N-epitope phosphorylated synthetic peptide taken within amino acid region 200-300 on human Src protein. Phosphorylated Tyr-215 residue.
|
Accession #
|
NCBI: NP_005408.1
|
Physical Properties
|
|
Quantity
|
250 µg
|
Volume
|
100 µl
|
Form
|
Antigenic Blocking Peptide
|
Determinant
|
N-epitope
|
Storage
|
-20⁰C for long term storage
|
Application Protocol
|
Competition/Depletion assay
|
Refer to competition assay protocol
|
Protein
|
Uniprot #
|
P12931
|
Overview
|
Participates in signaling pathways that control a diverse spectrum of biological activities including gene transcription, immune response, cell adhesion, cell cycle progression, apoptosis migration, and transformation.
|
Molecular Function
|
ATP binding, ephrin receptor binding, heme binding, ion channel binding, enzyme binding, growth factor receptor binding, integrin binding, kinase activity
|
Subcellular Location
|
Cell membrane, mitochondrion inner membrane, nucleus, cytoplasm (Note: Localizes to focal adhesion sites following integrin engagement. Localization to focal adhesion sites requires myristoylation and SH3 domain.)
|
Expression
|
Expressed ubiquitously. Platelets, neurons and osteoclasts express 5-fold to 200-fold higher levels than most other tissues.
|
Alternative Nomenclature
|
ASV antibody
Avian sarcoma virus antibody
Neuronal CSRC tyrosine specific protein kinase antibody
p60 Src antibody
SRC1 antibody
Tyrosine kinase pp60c src antibody
v src avian sarcoma (Schmidt Ruppin A2) viral oncogene homolog antibody
|
|
|